- News & Insights
- Asia & Beyond
Starting July 2020, RHTLaw Asia is proud to bring you a series of blockchain themed webinars, which are industry focused and tailored to address the various issues surrounding this new technology.
Join us in this fireside chat as we discuss the emergence of blockchain in healthcare and life sciences industry. Still at a relatively early stage of adoption, the use of blockchain in the healthcare industry presents many opportunities in a number of healthcare-related fields. While the benefits of blockchain are exciting, we also delve deeper to consider issues surrounding sensitive data and patient privacy, uses of smart contracts and how blockchain-based businesses can build a solid contractual framework to support their business model.
This webinar is brought to you in collaboration with Perlin.
Don’t miss this webinar where we will discuss regulatory, contracts and data privacy issues for the application of blockchain in healthcare and life sciences industry.
|Professor Leslie Chew|
Dean, School of Law, Singapore University of Social Sciences
|Professor Leslie Chew has 42 years of legal experience, seven years of which was in the judiciary as a Senior District Judge and was appointed Senior Counsel by the Supreme Court – Singapore’s equivalent of the Queen’s Counsel in England – in 2000. Professor Chew practices primarily at the Commercial Bar. From time to time he has represented clients in commercial crime or white collar cases. He has acted as counsel for major banks in Singapore and a number of private banks. He has also acted in medical cases on behalf of the restructured hospitals and private hospitals. He is an accomplished commercial arbitrator and has practised as an arbitrator and arbitration counsel since 1993. He has sat as presiding arbitrator and co-arbitrator in SIAC, ICC and UNCITRAL arbitrations in various jurisdictions including India, Nepal and South Korea. He was a former president of the Singapore Institute of Arbitrators and is a Fellow of the Chartered Institute of Arbitrators.|
|Dorjee Sun is a successful serial social and tech entrepreneur and WEF Young Global Leader, who has co-founded 20 companies and advised a host of prominent blockchain projects. His work has been the subject of an award-winning documentary and global media, including the WSJ, Fortune, TIME, Forbes, Esquire, ABC, PBS, BBC, Discovery, CNBC and more.|
|Chester Lee Drum|
|Chester Drum, M.D. Ph.D., is a senior consultant and life-long patient advocate with appointments at the National University Hospital and the National University of Singapore. Dr. Drum received an M.D. and Ph.D. from the University of Chicago and completed a cardiology fellowship at the Brigham and Women’s Hospital in Boston. He then worked with Institute Professor Robert Langer at the Massachusetts Institute of Technology and received the Burroughs Wellcome Career Award for Medical Scientists. After moving to Singapore, he has been a recipient of a Clinician Scientist Award from the NMRC, funding from the BMRC and multiple innovation awards from the Singapore MIT Alliance for Research and Technology (SMART). Doctor Drum has over 20 years of clinical experience in managed care, private, public and academic healthcare settings in both the US and Asia. He is the holder of multiple patents and his research has been featured in publications such as the New York Times and Nature. His current research focusses on the use of deep phenotyping techniques to predict and improve patient outcomes. To ensure real world impact of biomarker data, Dr. Drum has co-developed a distributed ledger system for medical information sharing and validation which is being trialed in multiple settings.|
|Ch’ng Li-Ling is one of the founding members of RHTLaw Asia and heads the Financial Services (Regulatory) Practice. Her areas of practice include corporate and securities laws, capital markets, mergers and acquisitions, securities and financial services regulatory compliance, and corporate governance. She advises financial institutions, FinTech firms and investors on acquisitions and capital-raising, on MAS licensing and regulatory requirements for capital markets services providers, operators of organised markets and payment services providers on digital token issuances and the establishment of digital assets exchanges and e-payments platforms.|
|Erwan Barre is a Partner (Foreign Lawyer) at RHTLaw Asia and the Co-Head of our Corporate and Capital Markets Practice. He also heads our Healthcare & Life Science Industry Group. He joined RHTLaw Asia in 2015 after practicing for 16 years with Sullivan & Cromwell and Paul Hastings, two leading US law firms, in Paris and New York. Focused on corporate transactions, Erwan has extensive experience representing clients across many industries, with an emphasis in the Technology and Life Science industries. Erwan has been involved in many M&A, joint venture, capital markets and financing projects in Asia, Europe and the US, including several game changing transactions. Most of these deals were cross-border. Erwan Barre, our co-head of practice was recently recognized as one of the world’s leading practitioners in Who’s Who Legal Healthcare 2020 Edition.|
|Rizwi is one of the founding members of RHTLaw Asia. He has been in practice for about 20 years and is the Acting Head of the Firm’s Intellectual Property & Technology Practice. Rizwi’s main areas of legal practice covers the creation, protection, commercialisation and enforcement of intellectual property in Singapore, and also in the region. Rizwi also advises on legal and regulatory aspects of technology-related matters, with particular emphasis on Data Protection, Cyber Security, and Competition Law issues. He contributes regularly on topics including life sciences research, data protection, and franchising and has been featured, most recently in 2016, in the Singapore Business Times and Bloomberg Asia relating to issues on cyber security and data protection.|